Search

Your search keyword '"Papp TE"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Papp TE" Remove constraint Author: "Papp TE"
19 results on '"Papp TE"'

Search Results

1. Sustainable finance: The relating actual Hungarian legislation in EU frame

2. The acquisition of real estate by timesharing contract in Europe

3. In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis.

4. In Situ Tumor Vaccination Using Lipid Nanoparticles to Deliver Interferon-β mRNA Cargo.

5. An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA.

6. Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy.

7. Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke.

8. Lipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape Without Side Effects.

9. IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation.

10. Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system.

11. In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism.

12. In vivo hematopoietic stem cell modification by mRNA delivery.

13. Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke.

14. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE).

15. CAR T cells produced in vivo to treat cardiac injury.

16. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs.

17. AKT3 Gene Transfer Promotes Anabolic Reprogramming and Photoreceptor Neuroprotection in a Pre-clinical Model of Retinitis Pigmentosa.

18. Identification of a novel pathogenic missense mutation in PRPF31 using whole exome sequencing: a case report.

19. CRISPR Activation Enhances In Vitro Potency of AAV Vectors Driven by Tissue-Specific Promoters.

Catalog

Books, media, physical & digital resources